Log In

Term Description

Some computer edits identify errors. Others indicate possible errors that require manual review for resolution. To eliminate the need to review the same cases repeatedly, over-ride flags have been developed to indicate that data in a record (or records) have been reviewed and, while unusual, are correct. This over-ride is used with the following edits in the NAACCR Metafile of the EDITS software: Primary Site, Morphology-Type Check (SEER IF25) Primary Site, Morphology-Type Check ICDO3 (SEER IF25)

Some edits check for code combinations that are possible, but quite rare. If the code combination generates an error message and review of the case indicates that the codes are correct for the case then the over-ride flag is used to skip the edit in the future. See Chapter IV, Recommended Data Edits and Software Coordination of Standards. Over-ride Flag as Used in the EDITS Software Package Multiple versions of edits of the type Primary site, Morphology-Type check for "usual" combinations of site and ICD-O-2 or ICD-O-3 histology. The SEER version of the edit is more restrictive than the COC edit, and thus uses a different over-ride flag. The COC version of the edit will accept Over-ride COC-Site/Type or Over-ride Site/Type as equivalent. The Site/Histology validation list (available on the SEER web site) contains those histologies commonly found in the specified primary site. Histologies that occur only rarely or never are not included. These edits require review of all combinations not listed. Since basal and squamous cell carcinomas of non-genital skin sites are not reportable to SEER, these site/histology combinations do not appear on the SEER validation list. For the COC version of the edit, if Primary Site is in the rage C440-C449 (skin), and Histologic Type ICD-O-3 is in the range 8000-8005 (neoplasms, malignant, NOS), 8010-8046 (epithelial carcinomas), 8050-8084 (papillary and squamous cell carcinomas), or 8090-8110 (basal cell carcinomas), no further editing is done. No over-ride is necessary for these cases in the COC version of the edit. Review of these cases requires investigating whether a) the combination is biologically implausible, or b) there are cancer registry coding conventions that would dictate different codes for the diagnosis. Review of these rare combinations often results in changes to the primary site and/or morphology, rather than a decision that the combination is correct. Instructions for Coding Leave blank if the program does not generate an error message for the edit Primary Site, Morphology-Type Check (SEER IF25) and/or the edit Primary Site, Morphology-Type ICDO3 (SEERIF25). Leave blank and correct any errors for the case if an item is discovered to be incorrect. Code 1 if the case has been reviewed and both the site and histology are correct... NAACCR Data Standards and Data Dictionary Version 11

LOINC Names Get Info

Fully-Specified Name
Site&type override flag:Arb:Pt:Cancer case.XXX:Ord:
Long Common Name
Siteandtype override flag Cancer case
Short Name
Site/type O/R Cancer case

Part Model Get Info

  • Component
    Site&type override flag
    LP73360-7
    • Analyte
      Site&type override flag
      LP73360-7
      • Component Numerator
        Site&type override flag
        LP73360-7
        • Component Numerator Core
          Site&type override flag
          LP73360-7
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    Arb
    LP6781-1
  • Time
    Pt
    LP6960-1
  • System
    Cancer case.XXX
    LP7100-3
    • System Core
      Cancer case.XXX
      LP7100-3
    • Super System
      NULL
       
  • Scale
    Ord
    LP7751-3
  • Method
    NULL
     

Normative Answer List: LL152-0

AnswerCodeScoreAnswer ID
Reviewed1LA4354-2
Not reviewedBlankLA4694-1

Basic Attributes

Class
TUMRRGT
Type
Clinical
First Released
Version 1.0m
Last Updated
Version 2.38 (MIN)

Member of these Panels

LOINCLong Common Name
49083-9North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 11 panel
59852-4North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel

Language Variants Get Info

TagLanguageTranslation
el-GRGreek (Greece)Σήμανση παράκαμψης θέσης&τύπου:Arb:Pt:Περιστατικό καρκίνου.XXX:Ord:
Synonyms: Arb Ord Pt TUMRRGT Type XXX Καρκίνος Περιστατικό καρκίνου.XXX Σήμανση παράκαμψης θέσης&τύπου
es-ARSpanish (Argentina)SITE&TYPE OVERRIDE FLAG:arbitrario:punto en el tiempo:caso de cáncer.XXX:ordinal:
es-MXSpanish (Mexico)Indicador de anulación de sitio y tipo:Arb:Punto temporal:Caso de cáncer XXX:Ordinal:
it-ITItalian (Italy)Sito&tipo, flag ignorato:Arb:Pt:Cancro, caso.XXX:Ord:
Synonyms: Arbitrario Caso di cancro XXX Caso di neoplasia maligna XXX Flag ignorato per sito e tipo Neoplasia maligna Punto nel tempo (episodio) Registro tumori
ru-RURussian (Russian Federation)Локализация&тип переопределение флаг:Произв:ТчкВрм:Рак случай.XXX:Пор:
Synonyms: Порядковый Произвольный Случай рака XXX Точка во времени;Момент
zh-CNChinese (China)部位与类型重写标记:任意型:时间点:癌症病例.XXX:序数型:
Synonyms: NAACCR 肿瘤登记;癌症登记中心北美协会肿瘤登记;肿瘤注册;肿瘤登记（NAACCR）;肿瘤登记（癌症登记中心北美协会）;癌症登记中心北美协会;North American Association of Central Cancer Registries;NAACCR 不明的;其他;将在相应消息内其他部分之中加以详细说明;未作详细说明的;未作说明的;未做说明的标本;未加规定的;未加说明的标本;杂项 不明的癌症个案;不明的癌症案例;不明的癌症病例;未作说明的癌症个案;未作说明的癌症案例;未作说明的癌症病例;癌症个案.XXX;癌症个案.不明;癌症个案.未作说明的;癌症案例.XXX;癌症案例.不明;癌症案例.未作说明的;癌症病例.不明;癌症病例.未作说明的;此处未作说明的癌症病例 任意;任意的;人工型 位点;位置 依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型 型 时刻;随机;随意;瞬间 癌 癌症个案 癌症案例 部位与类型覆盖标记;部位与类型重写标志

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=21995-6